By the way, I called Teva as well as the local clinical trial center again today. They are still recruiting for the CHF study. Just to remind everyone that it has been 4 days after my initial call. For the negative types, it does not matter, I know. I called again today, not because I doubt. I called because I still see posts that speculate that Teva might have pulled out.
If it is to be inferred - because a trial program is still active four days after it is speculated that Teva has terminated a strategic agreement to fund such a trial - that it therefore means that such speculation must be wrong, this suggests that Mesoblast initially entered into the partnership agreement without requiring Teva to provide Mesoblast with any notice whatsoever in the event that Teva sought to end its participation in the trial.
Are you really saying that Mesoblast and its legal advisors would enter into a commercial arrangement whereby a counter-party who was funding a critical trial could pull up stumps with no notice period whatsoever, and therefore cause the trial to stall, and to probably even be jeopardised?
I would have thought you would regard MSB executives as being far more commercially astute than that.
- Forums
- ASX - By Stock
- Added some today
By the way, I called Teva as well as the local clinical trial...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23940 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 22571 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13940 | 1.390 |
1 | 14000 | 1.385 |
2 | 15350 | 1.370 |
2 | 20000 | 1.355 |
2 | 2400 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 22571 | 2 |
1.400 | 108300 | 3 |
1.405 | 39000 | 3 |
1.410 | 1430 | 1 |
1.415 | 67966 | 3 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online